dose day drift is mostly harmless with a weekly compound, but pick a day and defend it
the ladder in the trials is a starting point, not a schedule you owe anyone
#dosing-titration 2025-07-28
- night_pin — dose day drift is mostly harmless with a weekly compound, but pick a day and defend it the ladder in the trials is a starting point, not a schedule you owe anyone 11:48
- slow.taper — with a roughly seven day half-life you are near steady state after about five weeks at a dose 13:19
- night_pin — came down from a treatment dose to maintenance over about three months and it was uneventful, ill dig out the number holding is not failing. most people here who… 13:23
- verify_or_dont — i went to the top of the ladder, felt no better than two rungs down, and came back. that is data for me and nobody else 14:28
thats noise
came down, no regrets
thats normal
i went from 1.7 to 2.4 and honestly could not tell the difference in appetite
the honest answer is that most of us are running protocols nobody has ever studied
held for months
if i hold at 7.5 indefinitely am i losing anything
plateau versus set point is not answerable in under six months of data
two weeks is nothing
with a roughly seven day half-life you are near steady state after about five weeks at a dose
n of 1
came down from a treatment dose to maintenance over about three months and it was uneventful, ill dig out the number
holding is not failing. most people here who lasted two years held at least one dose for months
end of week thing
thats anecdote
steady state is 5 weeks
if it "stopped working after four days" that is almost never pharmacokinetics, take that with a pinch of salt
half life is a week
if you are asking whether to go up, the fact you are asking usually means not yet
not advice
quick one split dosing has no trial behind it. people here do it and report on it, thats all
how do you tell a plateau from just being at your set point
i went to the top of the ladder, felt no better than two rungs down, and came back. that is data for me and nobody else